Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Etanercept
Enbrel
Routinely available
NICE (TA455 (SMC 570/09))
01/09/2009

Indication

Chronic severe plaque psoriasis in children and adolescents

Chronic severe plaque psoriasis in children and adolescents

Therapeutic Area

Skin

Status Description

Routinely available in line with national guidance

Formulation

Solution for injection

Comments

September 2009 - Added to the Additional List. For Specialist Use only. July 2017 - NICE MTA advice: SMC advice 570/09 is superseded by NICE TA455. June 2019 (as per LJF) - Routinely available in line with national guidance. Included in the Additional List, for Specialist Use only.

Link to Advice

TA455 (SMC 570/09)

Advice Published

12/07/2017